Andreas E. Ziegler

Albert Einstein Allee 11
Ulm, BW 89069, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 240 publications

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

Journal: Journal of neuromuscular diseases

Published: August 27, 2026

In Reply.

In Reply.

Journal: Deutsches Arzteblatt international

Published: June 16, 2026

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

Journal: International journal of molecular sciences

Published: April 11, 2026

Urinary Metabolomics Predict Acute Kidney Injury in Very-Low-Birth-Weight Infants with Patent Ductus Arteriosus.

Urinary Metabolomics Predict Acute Kidney Injury in Very-Low-Birth-Weight Infants with Patent Ductus Arteriosus.

Journal: Biomolecules

Published: January 16, 2026

The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study.

The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study.

Journal: EClinicalMedicine

Published: December 17, 2025

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.

Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.

Journal: Journal of neuromuscular diseases

Published: November 24, 2025

Revealing the Intricate Structure of Surface Phases of Methanol on In2O3(111).

Revealing the Intricate Structure of Surface Phases of Methanol on In2O3(111).

Journal: The journal of physical chemistry. C, Nanomaterials and interfaces

Published: October 13, 2025

Associations between cardiovascular risk factors and diseases with aortic pulse wave velocity and aortic distensibility: magnetic resonance imaging in the Hamburg city health study.

Associations between cardiovascular risk factors and diseases with aortic pulse wave velocity and aortic distensibility: magnetic resonance imaging in the Hamburg city health study.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: October 07, 2025

Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study.

Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study.

Journal: Journal of neuromuscular diseases

Published: September 12, 2025

Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population.

Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population.

Journal: Journal of the American College of Cardiology

Published: September 08, 2025

Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis.

Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk: An Individual Participant Data Meta-Analysis.

Journal: JAMA cardiology

Published: August 30, 2025

Considerations driving the choice in clinical trial design of cell and gene therapy products: weighing convenience versus necessity.

Considerations driving the choice in clinical trial design of cell and gene therapy products: weighing convenience versus necessity.

Journal: Cytotherapy

Published: May 12, 2025

Showing 1-12 of 240

Last Updated: 09/26/2026